4.6 Article

How patients' attitudes and opinions influence self-care behaviours in type 2 diabetes. Insights from the French DIABASIS Survey

Journal

DIABETES & METABOLISM
Volume 36, Issue 6, Pages 476-483

Publisher

MASSON EDITEUR
DOI: 10.1016/j.diabet.2010.08.004

Keywords

Type 2 diabetes; Patient profiles; Behaviour; Beliefs; Self-management

Funding

  1. Novartis Pharmaceuticals Corporation
  2. Novartis
  3. Abbott
  4. Amgen
  5. Astra-Zeneca
  6. Bayer
  7. Boehringer Ingelheim
  8. Eli Lilly
  9. GlaxoSmithKline
  10. LifeScan
  11. Merck Sharp Dohme-Chibret
  12. Novo Nordisk
  13. Pfizer
  14. Roche Diagnostics
  15. Roche Pharma
  16. Sankyo
  17. Sanofi Aventis
  18. Servier
  19. Takeda
  20. Therval
  21. Merck-Lipha

Ask authors/readers for more resources

Aim. - This study evaluated the profiles of patients with type 2 diabetes (T2DM) to identify sets of opinions and attitudes towards the disease that might influence self-care behaviours. Methods. - Altogether, 1,092 patients with T2DM, aged 45 or older from a large representative French cohort, completed a self-questionnaire exploring their knowledge and perceptions of diabetes, its impact on various aspects of daily life and self-management practices. Canonical and cluster analyses were used to identify sets of homogeneous 'profiles' of patients linking attitudes and opinions to specific disease-related behaviours (such as changes in lifestyle, drug compliance, treatment satisfaction, impact on everyday life and weight gain). Results. - Demographics of the T2DM study population were previously reported along with the main results (60% male; mean age: 66 years; mean age at diagnosis: 55 years; mean BMI: 29 kg/m(2)). Five distinct patient types emerged from the typological approach: 'committed' (25%); 'carefree' (23%); 'bitter' (19%); 'disheartened' (19%); and 'overwhelmed' (15%). Each patient type defined a set of attitudes and beliefs towards T2DM that influenced disease-related behaviours, leading to different degrees of diabetes self-management. Conclusion. - The DIABASIS survey provides important information for diabetes care by identifying distinct patients' profiles that express different degrees of difficulty in implementing self-management. For this reason, patients in each category require different kinds of customized support from their physician to induce behavioural changes that may be key in improving their metabolic control. (C) 2010 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available